Local Institution - 0131

Seoul 3080

1 studies enrolling now · 3 studies all time

What they study most

Esophageal Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer, Various Advanced Cancer

Studies at this site

• Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) — Starting soon
• A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin — Completed
• Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer — Completed